Dr. Roumie honored with VUMC Biomedical Science Impact Award

April 13, 2020

From VUMC Office of Research: "We are pleased to honor you with a VUMC Biomedical Science Impact Award in recognition of your high impact research contributions to Vanderbilt University Medical Center. The award specifically recognizes your 2019 publication in the Journal of the American Medical Association titled “Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function”. In addition, we will present you with a crystal award in honor of this achievement."   

Study launched to test hydroxychloroquine as treatment for COVID-19

April 8, 2020

Faced with a global pandemic of a virus previously unknown to humans, Vanderbilt University Medical Center (VUMC) is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19.

Vanderbilt team develops COVID-19 predictive model for Tennessee

April 6, 2020

A team including health economists, epidemiologists and a biostatistician at Vanderbilt University Medical Center and Vanderbilt University are amassing and processing data to develop a complex predictive model of the spread of COVID-19 within Tennessee, with region-specific projections, as well as a model of projected resource use during response to the pandemic.

Study aims to shield health workers from COVID-19 infection

VUMC Reporter
April 2, 2020

Vanderbilt University Medical Center is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19. The Board of Governors of the non-profit Patient-Centered Outcomes Research Institute (PCORI) in Washington, D.C., today approved up to $50 million to fund the initiative, known as the Healthcare Worker Exposure Response and Outcomes (HERO) research program, to be led by the Duke Clinical Research Institute (DRCI). Co-chairs of the HERO Steering Committee are Russell Rothman, MD, MPP, VUMC Senior Vice President for Population and Public Health, and Judith Currier, MD, professor of Medicine and chief of the Division of Infectious Diseases at UCLA Medical Center, Santa Monica. Fellow steering committee member Sean Collins, MD, MSCI, professor and executive vice chair of the Department of Emergency Medicine at VUMC, will lead VUMC’s engagement in the HERO study and will serve as the site’s principal investigator. He also is a member of the protocol advisory committee.

Post intensive-care syndrome': Why some COVID-19 patients may face problems even after recovery

By Erika Edwards, NBC News
April 2, 2020
Posted in

"ICU patients need "to have humans around to orient them, to calibrate them, to touch them, to look in their eyes, and make them understand what's happening," Dr. E. Wesley Ely, a professor of medicine and critical care at Vanderbilt University, said. "But that's exactly what the COVID patients won't get because they're all being isolated." Ely said physicians are learning about the specific impact of COVID-19 on post-ICU syndrome from countries that have already had large numbers of cases."

Study aims to shield health workers from COVID-19 infection

April 2, 2020

Vanderbilt University Medical Center is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19.

Today, on National Doctors’ Day, Music Row and Nashville’s creative community are coming together to support the Vanderbilt University Medical Center staff through the launch of ‘Gratitunes.’

VUMC Reporter
March 31, 2020

Today, on National Doctors’ Day, Music Row and Nashville’s creative community are coming together to support the Vanderbilt University Medical Center staff through the launch of ‘Gratitunes.’ ‘Gratitunes’ is a consumer-generated music platform to celebrate and thank members of the VUMC family, through the power of music, for their dedication, empathy and unwavering commitment during the COVID-19 pandemic. Brad Paisley will kick-off the program with the first dedicated ‘Gratitune’ from his Instagram today.

Vanderbilt Divinity and VA partner on doctor of ministry for chaplains

VUMC Reporter
March 6, 2020
Posted in

A new partnership between Vanderbilt Divinity School and Mental Health and Chaplaincy, a national program of the U.S. Department of Veterans Affairs’ Veterans Health Administration, will relaunch a doctor of ministry program at Vanderbilt. The program aims to equip chaplains with best practices for providing high-quality, evidence-based care for persons with diverse psychosocial–spiritual needs. “I am excited that we are relaunching our Doctor of Ministry program with this first track on integrative chaplaincy,” said Emilie M. Townes, dean of the Divinity School and the E. Rhodes and Leona B. Carpenter Professor of Womanist Ethics and Society. “This track will integrate spirituality and mental health in a hybrid online/in-person class format that engages students who are actively functioning as chaplains. They will be able to apply their coursework to their contexts immediately.”

VIGH’s Trevathan appointed to NINDS Advisory Council

VUMC Reporter
January 20, 2020

Edwin Trevathan, MD, MPH, director of the Vanderbilt Institute for Global Health (VIGH), has been appointed to the Advisory Council for the National Institute for Neurological Diseases and Stroke (NINDS) of the National Institutes of Health. Trevathan, the Amos Christie Chair in Global Health and professor of Pediatrics and Neurology, will serve a four-year term on the National Advisory Neurological Disorders and Stroke Council (NANDSC). The advisory council meets three times a year to provide guidance to the NINDS director on programming, reviews and reports on intramural and extramural programs.